Mar 13, 2020   SOURCE: PR NewsWire

Global Medical Device Partnering Terms & Agreements 2014-2020: Deal Trends, Players and Financials

DUBLIN, March 13, 2020 /PRNewswire/ -- The "Global Medical Device Partnering Terms and Agreements 2014-2020: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering.

https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

Global Medical Device Partnering Terms and Agreements 2014-2020 provides a detailed understanding and analysis of how and why companies enter Medical Device partnering deals.

    --  Trends in Medical Device dealmaking in the biopharma industry since 2014
    --  Analysis of Medical Device deal structure
    --  Access to headline, upfront, milestone and royalty data
    --  Case studies of real-life Medical Device deals
    --  Access to Medical Device contract documents
    --  Leading Medical Device deals by value since 2014
    --  Most active Medical Device dealmakers since 2014

This report provides details of the latest Medical Device agreements announced in the life sciences since 2014.

The report takes the reader through a comprehensive review Medical Device deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Medical Device partnering deals.

The report presents financial deal term values for Medical Device deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.

The middle section of the report explores the leading dealmakers in the Medical Device partnering field; both the leading deal values and most active Medical Device dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.

One of the key highlights of the report is that over 2,300 online deal records of actual Medical Device deals, as disclosed by the deal parties, are included towards the end of the report in a directory format - by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.

In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.

The initial chapters of this report provide an orientation of Medical Device dealmaking.

    --  Chapter 1 provides an introduction to the report, whilst chapter 2
        provides an overview of the trends in Medical Device dealmaking since
        2014, including details of headline, upfront, milestone and royalty
        terms.
    --  Chapter 3 provides a review of the leading Medical Device deals since
        2014. Deals are listed by headline value. Where the deal has an
        agreement contract published at the SEC a link provides online access to
        the contract.
    --  Chapter 4 provides a comprehensive listing of the top 25 most active
        companies in Medical Device dealmaking with a brief summary followed by
        a comprehensive listing of Medical Device deals announded by that
        company, as well as contract documents, where available.
    --  Chapter 5 provides a comprehensive and detailed review of Medical Device
        partnering deals signed and announced since Jan 2014, where a contract
        document is available in the public domain. Each deal title links via
        Weblink to an online version of the deal record and contract document,
        providing easy access to each contract document on demand.
    --  Chapter 6 provides a comprehensive and detailed review of Medical Device
        partnering deals signed and announced since Jan 2014. The chapter is
        organized by specific technology type. Each deal title links via Weblink
        to an online version of the deal record and where available, the
        contract document, providing easy access to each deal on demand.

A comprehensive series of appendices is provided organized by Medical Device partnering company A-Z, stage of development, deal type, and therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Medical Device partnering and dealmaking since 2014.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Medical Device technologies and products.

Analyzing actual contract agreements allows assessment of the following:

    --  What are the precise rights granted or optioned?
    --  What is actually granted by the agreement to the partner company?
    --  What exclusivity is granted?
    --  What is the payment structure for the deal?
    --  How aresalesand payments audited?
    --  What is the deal term?
    --  How are the key terms of the agreement defined?
    --  How are IPRs handled and owned?
    --  Who is responsible for commercialization?
    --  Who is responsible for development, supply, and manufacture?
    --  How is confidentiality and publication managed?
    --  How are disputes to be resolved?
    --  Under what conditions can the deal be terminated?
    --  What happens when there is a change of ownership?
    --  What sublicensing and subcontracting provisions have been agreed?
    --  Which boilerplate clauses does the company insist upon?
    --  Which boilerplate clauses appear to differ from partner to partner or
        deal type to deal type?
    --  Which jurisdiction does the company insist upon for agreement law?

Companies Mentioned 

    --  1A Pharma
    --  2XU
    --  3B Medical
    --  3D-Micromac
    --  3D Systems
    --  3M
    --  3PrimeDx
    --  4D Pharma
    --  4WEB Medical
    --  7D Surgical
    --  11 Health and Technologies
    --  20/20 GeneSystems
    --  36 Strategies General Trading
    --  121nexus
    --  480 Biomedical
    --  908 Devices
    --  A&B Company
    --  A&D Medical
    --  A&E Medical
    --  A*STAR Agency for Science
    --  Technology and Research
    --  AAP Implantate AG
    --  Aarhus University Hospital
    --  Abaxis
    --  Abbott Laboratories
    --  Abbvie
    --  Abiomed
    --  Ab Medica
    --  Abyrx
    --  Acacia
    --  Acacia Research
    --  Academy Medical
    --  Acare Medical Science
    --  Accelerate Diagnostics
    --  Access Scientific
    --  Accuray
    --  AccuTec Blades
    --  Acelity
    --  Acell
    --  Acoustic MedSystems
    --  Actavis (name changed to Allergan)
    --  Actelion
    --  ACT Genomics
    --  Activbody
    --  ActLight
    --  Actuated Cardio Engineering
    --  Actuated Medical
    --  Acucela
    --  Acuna-Fombona
    --  Acutus Medical
    --  Adachi
    --  ADB International Group
    --  AddUp
    --  Adept Neuro
    --  Adherium
    --  Adhesys Medical
    --  Adimab
    --  Admedus
    --  ADM Tronics
    --  Advanced Accelerator Applications
    --  Advanced Analytical Technologies
    --  Advanced Animal Diagnostics
    --  Advanced Biologics
    --  Advanced Catheter Therapies
    --  Advanced Cell Diagnostics
    --  Advanced Cooling Therapy
    --  Advanced Medical German Company of Kuwait
    --  Advanced Medical Isotope
    --  Advanced Plasma Products
    --  Advanced Prenatal Therapeutics
    --  Advanced Radiation Therapy
    --  AdvanSource Biomaterials
    --  Advantage Consumer Healthcare
    --  Adventus Ventures
    --  Aerocrine
    --  Aerogen
    --  Aerolase
    --  Aesculap
    --  Aethlon Medical
    --  Aethon
    --  Aetna
    --  Afaxys Pharmaceuticals
    --  AFFiRiS
    --  AgaMatrix
    --  Agilent Technologies
    --  Aglon
    --  Agrium
    --  AGTC
    --  Aier Eye Hospital Group
    --  AIM Plastics
    --  Aircraft Medical
    --  Aires Pharmaceuticals
    --  Air Force General Hospital
    --  AirStrip Technologies
    --  AirWare Labs
    --  Aitbiotech
    --  Ajad Medical
    --  AJL Ophthalmic
    --  Akers Biosciences
    --  Akili Interactive Labs
    --  Akita Innovations
    --  Akron Biotechnology
    --  Alat Medika Indonesia
    --  Albany Molecular Research

    --  and many, many more...

For more information about this report visit https://www.researchandmarkets.com/r/739hkg

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.


Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-medical-device-partnering-terms--agreements-2014-2020-deal-trends-players-and-financials-301022914.html

SOURCE Research and Markets